Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
Key facts
- Who runs it
- Children's Hospital of Philadelphia
- Where
- Denver, Kansas City, Palo Alto, and Philadelphia, United StatesSee the 4 sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 15 Jul 2025
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Transpyloric tube feeding
- Gastric tube feeding
- Record updated
- 17 July 2026
Who can take part
- Age
- 1 month to 12 months
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Birth <32 weeks' gestation
- Current postmenstrual age of 36-65 weeks
- Grade 2-3 bronchopulmonary dysplasia (BPD: treatment with positive airway pressure at 36 weeks' PMA) or grade 1 BPD (treatment with ≤2L/min flow nasal cannular at 36 weeks' PMA) with subsequent need for prolonged positive airway pressure and full enteral tube feedings
- Treatment with positive airway pressure (high flow nasal cannula, non-invasive positive airway pressure, or invasive ventilation) at enrollment; (4) Full gastric tube feedings (≥100mL/kg/d) at the time of enrollment (5) Parental consent to participate; Note: At least 20 infants receiving invasive ventilation will be enrolled to enable endotracheal biomarker testing
Who cannot take part
- Transpyloric feedings received within 7d of enrollment
- Use of a gastric acid suppression, GI promotility drug, or caffeine within 7d of enrollment
- Plan to wean off positive airway pressure (for non-intubated subjects) or to be extubated to non-invasive support (for subjects receiving invasive ventilation) within the 2wk trial
- Active treatment with an investigational therapy as part of another interventional trial
- History of gastrostomy tube placement, gastric fundoplication, or bowel resection resulting in short gut with contraindication to transpyloric feeding
- Known intolerance to transpyloric feeding
- Persistent >20% endotracheal tube leak (for intubated subjects only)
- severe congenital or genetic abnormality that adversely affects GI or cardiopulmonary function
Where in United States
- Children's Hospital ColoradoDenver, United StatesContact: Kathleen Hannan, MD, MSCSTaking people
- Children's Mercy HospitalKansas City, United StatesContact: Krishna Dummula, MD, MPHNot yet recruiting
- Stanford UniversityPalo Alto, United StatesContact: Erik Jensen, MD, MSCETaking people
- Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Nicolas Bamat, MD, MSCETaking people
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if transpyloric tube feeding (feeding directly into the small intestine) versus gastric tube feeding tolerably and effectively reduces gastroesophageal reflux in infants born premature who have been diagnosed with bronchopulmonary dysplasia. The main questions this trial aims to answer are:
Read full original descriptionShow less
Does transpyloric as compared to gastric tube feeding result in differences in the amount of experienced hypoxemia (low oxygen level in the blood) or serious adverse events?
Does transpyloric as compared to gastric tube feeding reduce the frequency and severity of gastroesophageal reflux (GER) measured using 24 hour esophageal pH-multichannel intraluminal impedance (pH-MII) monitoring?
Participants will:
Undergo pre-trial 24 hour pH-MII monitoring to determine baseline severity of GER.
Be randomly assigned to receive transpyloric or gastric tube feeding for 2 weeks.
Undergo repeat pH-MII at the end of the 2 week trial to assess for change in GER.
Undergo continuous pulse oximetry to record level of hypoxemia during the 2 week trial.
Undergo saliva and airway (if supported by a breathing tube) fluid collection to measure biomarkers of GER.
Be monitored clinically for possible adverse events.
The 2 groups in the trial
- Transpyloric tube feedingTreatment being tested
Nasal or oral placed feeding tube with the distal end located within the second or third portion of the duodenum. Correct placement confirmed by radiograph.
- Gastric tube feedingTreatment being tested
Nasal or oral placed feeding tube with distal end located within the stomach. Correct placement confirmed by point of care aspirate pH testing or radiograph based on local clinical standard.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pilot Trial Comparing Transpyloric to Gastric Feeding in Very Preterm Infants With Bronchopulmonary Dysplasia
- Record updated
- 17 July 2026